Navigation Links
Omega-3 Marine and Plant Products Market Report - Forecast to 2018
Date:7/7/2013

DUBLIN, July 5, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/dfz3h3/omega3_marine) has announced the addition of the "Omega-3 Marine And Plant Products: Global Markets, Competitors And Opportunities- 2013-2018 Analysis And Forecasts" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Omega-3 fatty acids are fats commonly found in marine and plant oils. They are considered essential, meaning they cannot be synthesized by the human body, and are vital for normal metabolism. Omega-3 has benefits in terms of cardiovascular disease, inflammation, developmental disorders, psychiatric disorders and cognitive aging. The health benefits of Omega-3 fatty acids, primarily EPA and DHA, were discovered in the 1970s by researchers studying the Greenland Inuit Tribe, who consumed large amounts of fat from fish, but displayed virtually no cardiovascular disease.

The most widely available marine sources of EPA and DHA are cold water, oily fish, krill and algae. Plant sources of Omega-3 include flaxseed and chia seed.

Although Omega-3 fatty acids have been known as essential to normal growth and health since the 1930s, awareness of their health benefits has dramatically increased since the 1990s. Today, Omega-3 products are a multi-billion dollar industry that is growing more than 15% annually.

Additionally, profiles of 183 public and private companies involved in the Omega-3 industry as producers, distributors and retailers are given. The report also includes 31 tables and 9 figures.

Companies Mentioned (184)

including:

- Axellus AS
- Azantis
- By-Health Co., Ltd.
- Croda International
- DuPont
- EWOS
- Functional Products Trading SA
- Glanbia
- GlaxoSmithKline plc
- HSC
- Huatai Biopharm, Inc.
- IOI Imperial-Oel-Import
- J.R. Carlson Laboratories
- Kievit
- L'Oreal
- Lysi
- Myprotein, Inc.
- Nuseed
- Nutra Novus
- Omega Protein Corp
- OmegaTri AS
- Pfizer Consumer Healthcare
- Polaris
- Recordati SpA
- Swanson Health Products
- Swiss Herbal Remedies Limited
- Trader Joe's Company, Inc.
- U.S. Mills, Inc.

For more information visit http://www.researchandmarkets.com/research/dfz3h3/omega3_marine

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Omegafort SCC Launches Worlds Highest-Potency Omega-3 Supplement for Professional Athletes
2. Can Omega-3 Fish Oil Ward Off Post-Partum Depression
3. Viviscal Introduces New Extra Strength Supplement with 50% More AminoMar Marine Complex
4. SI-BONE, Inc. annuncia la pubblicazione dei dati sulla sicurezza della sorveglianza post-commercializzazione per i primi 5.319 pazienti trattati con il sistema di impianto iFuse Implant System
5. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
6. Cochlear Americas Receives FDA Approval for the First and Only Ear Level Accessory for Waterproof Hearing with Cochlear Implants
7. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
8. Medical Device & Implants, LLC to exhibit at MD&M East 2013
9. Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results
10. WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile
11. SynCardia Co-Founder Honored with Pioneer in Transplantation Award at ISHLT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... release fourth quarter and yearly financial results after ... management will host an investment-community conference call at ... on March 2 nd 2017 to discuss ...
(Date:2/23/2017)... , February 23, 2017 ... from increasing caseload for varicose veins in their body. ... globe are prompting the adoption of endovenous laser therapy ... global endovenous laser therapy market, published by ... of lifestyle choices and consequences of obesity have collectively ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
(Date:2/23/2017)... RI (PRWEB) , ... February 23, 2017 , ... ... today a new partnership with the Rhode Island Consortium for Autism Research and ... an opportunity for children with autism spectrum disorder (ASD) to see films in ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):